SCHEMBL3876864

SCHEMBL3876864

CC[C@@H](NC(=O)[CH]CC(F)(F)C(N)=O)C(=O)c1noc(-c2ccc(F)cc2)n1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TPH1 P17752 2/20 0.36
HDAC6 Q9UBN7 4/20 0.35
HDAC1 Q13547 3/20 0.35
AOC3 Q16853 4/20 0.35
HDAC8 Q9BY41 3/20 0.34
ALDH1A1 P00352 1/20 0.34
KMT2A Q03164 1/20 0.34
HDAC4 P56524 3/20 0.33
SMPD1 P17405 1/20 0.33
NPC1 O15118 1/20 0.32
TP53 P04637 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HCRTR1 O43613 1/20 0.31
HCRTR2 O43614 1/20 0.31
PPARG P37231 1/20 0.31
PPARD Q03181 1/20 0.31
PPARA Q07869 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3870031 1.00 TPH1 (0.36) TPH1HDAC6HDAC1AOC3HDAC8
SCHEMBL3870366 0.93 HDAC6 (0.42) HDAC6HDAC1AOC3HDAC8ALDH1A1
SCHEMBL3877472 0.77 TPH1 (0.41) TPH1HDAC6HDAC1AOC3HDAC8
SCHEMBL3870034 0.77 TPH1 (0.41) TPH1HDAC6HDAC1AOC3HDAC8
SCHEMBL3876874 0.77 TPH1 (0.41) TPH1HDAC6HDAC1AOC3HDAC8
SCHEMBL3869248 0.76 HDAC4 (0.39) HDAC6HDAC1HDAC8KMT2AHDAC4
SCHEMBL3877756 0.70 CTSS (0.47)
SCHEMBL3871946 0.70
SCHEMBL3870371 0.69 HDAC1 (0.44) TPH1HDAC6HDAC1AOC3HDAC8
SCHEMBL8290893 0.69 CTSS (0.41) HDAC1KMT2ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7482448-B2 Compounds and compositions as cathepsin inhibitors AVENTIS PHARMACEUTICALS INC. (US) 2009-01-27 US disclosed
EP-1682524-A1 NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2006-07-26 EP disclosed
WO-2005040142-A9 NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS AVENTIS PHARMA INC (US) 2005-06-09 WO disclosed
WO-2005040142-A1 NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2005-05-06 WO disclosed